Key result
Suppressing Mogat1 expression with antisense oligonucleotides in fasted mice reduced hepatic MGAT activity, triglyceride content, and PPARα target gene expression.
Mogat1 is induced by fasting and regulates liver PPARα activity, highlighting its role in the hepatic fasting response.
No immediate clinical implications; leaves open Mogat1 as a regulator of hepatic PPARα during fasting for mechanistic studies.
During prolonged fasting, the liver plays a central role in maintaining systemic energy homeostasis by producing glucose and ketones in processes fueled by oxidation of fatty acids liberated from adipose tissue. In mice, this is accompanied by transient hepatic accumulation of glycerolipids. We found that the hepatic expression of monoacylglycerol acyltransferase 1 ( Mogat1 ), an enzyme with monoacylglycerol acyltransferase (MGAT) activity that produces diacylglycerol from monoacylglycerol, was significantly increased in the liver of fasted mice compared with mice given ad libitum access to food. Basal and fasting-induced expression of Mogat1 was markedly diminished in the liver of mice lacking the transcription factor PPARα. Suppressing Mogat1 expression in liver and adipose tissue with antisense oligonucleotides (ASOs) reduced hepatic MGAT activity and triglyceride content compared with fasted controls. Surprisingly, the expression of many other PPARα target genes and PPARα activity was also decreased in mice given Mogat1 ASOs. When mice treated with control or Mogat1 ASOs were gavaged with the PPARα ligand, WY-14643, and then fasted for 18 h, WY-14643 administration reversed the effects of Mogat1 ASOs on PPARα target gene expression and liver triglyceride content. In conclusion, Mogat1 is a fasting-induced PPARα target gene that may feed forward to regulate liver PPARα activity during food deprivation.
No takes yet. Share an insight, caveat, or question.
Lutkewitte et al. (2019) studied Fasting response. Mogat1 antisense oligonucleotides (ASOs) vs. Control ASOs was evaluated on Hepatic MGAT activity, triglyceride content, and PPARα target gene expression. Suppressing Mogat1 expression with antisense oligonucleotides in fasted mice reduced hepatic MGAT activity, triglyceride content, and PPARα target gene expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: